Studies indicate that reduced glutathione supplementation supports healthy neuropsychological function in healthy adults [2]
Zhang Z, Lei M, Liu R, Gao Y, Xu M, Zhang M
It is not a medicine or therapeutic good and is not for human consumption, veterinary use, or clinical application.
BPC-157 works primarily at the injury site for local tissue repair, while TB-500 has more systemic effects on muscle repair, inflammation, and flexibility
Absolute Contraindications Active malignancy Pregnancy and lactation Severe hypoglycemia disorders Known hypersensitivity to IGF-1 Active proliferative retinopathy Relative Contraindications Diabetes mellitus Renal impairment Cardiac impairment History of hyperplasia Family history of certain cancers Severe hepatic impairment Dosing & Administration Starting Dose 2050 mcg/day subcutaneously Begin at the lower end for sensitive patients Assess tolerance for 12 weeks before titration Therapeutic Range 50120 mcg/day for most indications Maximum dose: 200 mcg/day Individualize dosing based on response and tolerance Cycling Protocol 46 weeks on therapy 4 weeks off therapy Helps prevent receptor desensitization Supports long-term efficacy Administration Guidelines Hypoglycemia Prevention: Always administer IGF-1 LR3 with or shortly after carbohydrate-containing meals
